Can Cortisone Cause Laminitis in Horses?

Corticosteroids are useful drugs in equine medicine, but they need extra caution in horses with metabolic risk, previous laminitis, obesity, PPID, or insulin dysregulation.

By Dr Duncan Houston

Cortisone has a scary reputation in horses.

Many owners have heard some version of the same warning: “Do not inject steroids. They can cause founder.” That fear is not completely imaginary, but it is also not the whole story.

In equine practice, “cortisone” usually refers to corticosteroid drugs such as triamcinolone, methylprednisolone, betamethasone, dexamethasone, or prednisolone. These drugs can be very effective for reducing inflammation, especially in joints affected by synovitis or osteoarthritis. They can also be used in selected allergic, skin, airway, immune-mediated, and inflammatory conditions.

The real question is not simply “is cortisone safe?” The better question is: which corticosteroid, which dose, which route, which horse, and what laminitis risk factors are already present?

Quick Answer

Corticosteroids do not appear to have a strong proven link with laminitis in healthy, metabolically normal adult horses when used appropriately, but the risk is not zero. The concern is higher in horses with insulin dysregulation, equine metabolic syndrome, PPID, obesity, a cresty neck, previous laminitis, older age, pony or native breed type, severe systemic disease, high total doses, or repeated steroid exposure. There is no guaranteed “safe dose” that prevents laminitis in every horse, so corticosteroid use should be based on individual risk assessment, careful dose tracking, metabolic screening where appropriate, and close monitoring after treatment. (RCVS Knowledge)

What Do People Mean by Cortisone in Horses?

Owners often use the word “cortisone” to describe corticosteroids or glucocorticoids.

These are anti-inflammatory drugs that can reduce pain, swelling, immune activity, and inflammation.

Common corticosteroids used in horses include:

• Triamcinolone acetonide

• Methylprednisolone acetate

• Betamethasone

• Dexamethasone

• Prednisolone

• Hydrocortisone in selected situations

In lameness practice, corticosteroids are most often discussed around joint injections. They may be injected into joints, tendon sheaths, bursae, or nearby soft tissue regions depending on the diagnosis and treatment goal.

UC Davis describes intra-articular corticosteroids such as triamcinolone, methylprednisolone, and betamethasone as effective, inexpensive, first-line anti-inflammatory tools for joint disease, but also notes that their use remains controversial because harmful effects can occur and repeated injections may affect cartilage. (Horse Report)

Why Are Corticosteroids Used in Horses?

Corticosteroids are used because inflammation hurts.

In joints, inflammation can cause:

• Lameness

• Effusion or swelling

• Reduced range of motion

• Pain during work

• Poor performance

• Progression of osteoarthritis

• Secondary compensation elsewhere in the body

Corticosteroids may be used to reduce inflammation in cases such as:

• Osteoarthritis

• Synovitis

• Joint capsule inflammation

• Selected hock, fetlock, stifle, coffin joint, or carpal problems

• Some tendon sheath or bursal inflammation

• Allergic skin disease

• Airway inflammation

• Selected immune-mediated disease

• Other inflammatory conditions under veterinary supervision

Merck Veterinary Manual notes that corticosteroids have historically been used for musculoskeletal disorders including osteoarthritis, myositis, and immune-mediated arthritis, but also emphasises that glucocorticoids should be used alongside therapies that target the underlying cause of disease. (Merck Veterinary Manual)

That last point matters. Cortisone can reduce inflammation. It does not magically fix poor hoof balance, bad footing, joint instability, overwork, tendon injury, poor conditioning, or a training program that keeps irritating the same joint.

Can Cortisone Cause Laminitis?

The best current answer is: possibly in susceptible horses, but the evidence does not support a simple “cortisone always causes laminitis” message.

A Veterinary Evidence knowledge summary found no conclusive evidence that therapeutic systemic corticosteroid use causes laminitis in healthy adult horses or ponies without underlying endocrine or severe systemic disease. It did find weak evidence of an association between multiple systemic corticosteroid doses and laminitis in horses with underlying endocrine disorders or severe systemic disease. (veterinaryevidence.org)

For intrasynovial corticosteroid use, a systematic review summarised by RCVS Knowledge found that reported laminitis incidence was low and similar to controls where controls were included, but also stressed that the available evidence is limited and mostly weak quality. The available evidence suggested no association between intrasynovial corticosteroid injection and laminitis in horses without concurrent risk factors. (RCVS Knowledge)

So the practical veterinary interpretation is:

• In a healthy, metabolically normal horse, the laminitis risk appears low.

• In a horse with insulin dysregulation, EMS, PPID, obesity, previous laminitis, or severe systemic disease, caution increases sharply.

• The absence of proof does not mean “no risk.”

• The correct approach is individual risk assessment, not blanket fear or casual use.

What Is Laminitis?

Laminitis is inflammation and failure of the laminae inside the hoof. These laminae suspend the coffin bone within the hoof capsule.

When laminitis develops, the horse may show:

• Foot pain

• Reluctance to move

• A rocked-back stance

• Shifting weight

• Strong digital pulses

• Warm hooves

• Short, pottery gait

• Lameness in more than one foot

• Difficulty turning

• In severe cases, coffin bone rotation or sinking

The most common modern concern is hyperinsulinemia-associated laminitis, where high insulin levels contribute to laminar damage. Merck Veterinary Manual notes that oral sugar testing and oral glucose testing correlate well with hyperinsulinemia-associated laminitis risk, and that insulin concentrations at or above 100 mcIU/mL indicate high laminitis risk in the context of management assessment. (Merck Veterinary Manual)

That is why corticosteroids matter more in metabolic horses. The issue is not just “steroid equals laminitis.” The issue is whether the drug pushes an already insulin-sensitive horse into a dangerous metabolic state.

Why Metabolic Horses Are Different

The horse at highest risk is not usually the lean, metabolically normal performance horse with no laminitis history.

The horse that makes vets pause is the easy keeper with a cresty neck, regional fat pads, previous laminitis, high insulin, PPID, or a history that screams “metabolic risk.”

Equine metabolic syndrome is associated with insulin dysregulation, increased regional fat deposition, difficulty losing weight, and high laminitis risk. UC Davis notes that EMS often affects thrifty equids such as ponies, donkeys, Arabians, and mustangs, and that EMS lowers the threshold for laminitis. (Center for Equine Health)

Merck Veterinary Manual also notes that PPID can worsen insulin dysregulation in horses that also have EMS, which is why older horses with possible PPID deserve extra attention before steroid decisions. (Merck Veterinary Manual)

In practice, this is where the risk changes:

A healthy horse receiving a carefully selected joint injection is one conversation.

A fat pony with a cresty neck, previous laminitis, and untested insulin is a completely different conversation.

Same drug class. Different risk universe.

What Does Recent Research Say About Triamcinolone?

Triamcinolone acetonide is one of the most commonly discussed corticosteroids in equine joint therapy.

A large retrospective observational cohort study reviewed horses treated with intrasynovial triamcinolone between 2007 and 2017. After exclusions and follow-up losses, 966 treated horses were compared with matched untreated horses. Laminitis incidence over the 4-month study period was identical in both groups: 3 out of 966 horses, or 0.31%. The authors concluded that intrasynovial triamcinolone did not increase laminitis risk in that study population, while also noting limitations such as loss to follow-up, many racehorses in the population, and possible clinician risk-based case selection. (SURE)

That sounds reassuring, but newer metabolic work adds nuance.

A controlled study using 9 mg intra-articular triamcinolone found significant endocrine and metabolic effects, including changes in ACTH, cortisol, glucose, and insulin. The authors reported hyperglycemia between 12 and 48 hours, hyperinsulinemia at 32 hours, and effects on oral sugar testing and TRH testing, recommending at least 2 days and up to 7 days between a single 9 mg intra-articular triamcinolone treatment and OST or TRH testing. (MDPI)

Another study found that an 18 mg intra-articular triamcinolone dose increased systemic insulin and glucose concentrations in horses without insulin dysregulation, although the changes were modest in that metabolically normal group. (ResearchGate)

So the updated clinical message is not “triamcinolone causes laminitis.”

It is: triamcinolone can have systemic metabolic effects, including insulin changes, even when injected into a joint. That matters most in horses already at risk.

What About Methylprednisolone?

Methylprednisolone acetate is another corticosteroid used in equine joint therapy.

It is often considered longer acting than triamcinolone and has historically been used in lower-motion joints, although modern practice varies widely.

The current Depo-Medrol label states that the average initial intrasynovial dose for a large synovial space in horses is 120 mg, with a range of 40 to 240 mg, and that smaller spaces require smaller doses. The same label warns that systemic effects are more likely when more structures are injected and total dose is higher. (DailyMed)

A 2025 JAVMA study reported that 80 mg total intra-articular methylprednisolone acetate, delivered as 20 mg per joint into multiple low-motion joints, did not cause significant insulin or glucose changes in metabolically normal horses. The authors still stated that more work is needed before methylprednisolone should be considered safe in insulin-dysregulated or laminitis-prone horses. (University of Kentucky)

That distinction is critical.

“Did not raise insulin in a small group of metabolically normal horses” is not the same as “safe for every EMS horse.”

Is There a Safe Dose of Cortisone for Horses?

There is no dose that guarantees laminitis will not occur in every horse.

This is the point I would make very clearly to owners.

A commonly cited guideline is that total triamcinolone dose should be kept around or below 18 mg per horse at one treatment, and older intra-articular therapy references list similar whole-body dose concepts. However, Tokawa’s systematic review discussion, summarised by The Horse, specifically emphasised that no safe dose has been reported in the literature that completely avoids laminitis development. (The Horse)

So the safer way to think about dosing is:

Decision point	Why it matters
Total corticosteroid dose	More total exposure can increase systemic effects
Number of joints or sites treated	More sites can increase total drug exposure
Drug selected	Triamcinolone, methylprednisolone, betamethasone, and dexamethasone differ
Route	Intra-articular, intrasynovial, extrasynovial, intramuscular, oral, and IV are not the same
Metabolic status	Insulin dysregulation and PPID change the risk discussion
Previous laminitis	Prior laminitis should always increase caution
Repeat frequency	Repeated exposure can compound risk and joint concerns
Joint health	Steroids reduce inflammation but do not fix the underlying disease process
Competition rules	Detection and withdrawal rules vary by governing body

The best dosing is not a number from a blog. It is the smallest effective dose, selected by the vet for the horse, the joint, the condition, and the risk profile.

Which Horses Are Higher Risk?

Corticosteroids should be used more cautiously in horses with:

• Previous laminitis

• Equine metabolic syndrome

• Insulin dysregulation

• PPID

• Obesity

• Cresty neck

• Regional fat pads

• Easy keeper phenotype

• Pony, donkey, native, or thrifty breed type

• Older age

• Current high pasture or high starch intake

• Active systemic illness

• Severe inflammatory disease

• Current endotoxemia or sepsis risk

• Repeated steroid exposure

• Multiple joints needing injection at one visit

• Recent unexplained foot soreness

UC Davis specifically states that corticosteroid use should be avoided in geriatric horses and horses with metabolic disorders such as EMS and PPID because they are at increased risk for complications including laminitis. (Horse Report)

In real-world practice, the horse that worries me most is not always the obvious arthritic horse. It is the “chubby but otherwise fine” pony or warmblood with a cresty neck that has never had insulin tested.

That horse may look normal until the day it does not.

Should Insulin Be Tested Before Corticosteroids?

In at-risk horses, yes, metabolic screening is sensible.

Testing may include:

• Resting insulin

• Oral sugar test

• Oral glucose test

• Baseline ACTH for PPID screening

• TRH stimulation test in selected PPID cases

• Body condition and cresty neck assessment

• Review of laminitis history

• Diet and pasture risk review

Merck Veterinary Manual describes resting insulin, oral sugar testing, and oral glucose testing as important tools for identifying insulin dysregulation and assessing laminitis risk. It also notes that PPID testing is important because PPID can worsen insulin dysregulation in horses affected by EMS. (Merck Veterinary Manual)

One important timing point: intra-articular triamcinolone can affect insulin, glucose, ACTH, and cortisol testing for several days. The 2024 controlled study suggested waiting at least 2 days and up to 7 days after a single 9 mg intra-articular triamcinolone treatment before performing oral sugar or TRH testing. (MDPI)

So if insulin testing is being used to guide risk, it is often better to test before corticosteroid treatment rather than after it.

How Worried Should You Be?

Low Risk

This is more likely when:

• The horse is lean and fit.

• There is no history of laminitis.

• There is no cresty neck or regional fat deposition.

• The horse has no known EMS or PPID.

• Insulin testing is normal.

• A low total corticosteroid dose is used.

• One or a small number of appropriate sites are treated.

• The horse is monitored after injection.

Action: corticosteroids may be reasonable if the diagnosis supports them. Discuss the drug choice, dose, rest period, and monitoring plan with your vet.

Moderate Risk

This is more likely when:

• The horse is overweight.

• The horse is an easy keeper.

• There is mild regional fat deposition.

• The horse has not been tested for insulin dysregulation.

• Multiple joints are being considered.

• The horse has mild previous foot soreness or unclear laminitis history.

• The horse is older and PPID has not been ruled out.

Action: consider insulin and ACTH screening before treatment. Discuss lower-risk alternatives, reduced total dose, staging injections, or non-steroid options.

High Risk

This is more likely when:

• The horse has known EMS.

• The horse has insulin dysregulation.

• The horse has PPID.

• The horse has a previous laminitis episode.

• The horse is obese or has a marked cresty neck.

• The horse is a pony, donkey, native breed, or highly thrifty type.

• The horse needs multiple sites treated.

• The horse is currently on lush pasture or high non-structural carbohydrate feed.

Action: corticosteroids should be used only with a very clear reason and a risk mitigation plan. Alternatives may be safer.

Critical Risk

This is more likely when:

• The horse currently has active laminitis.

• The horse has recent unexplained foot pain.

• The horse has uncontrolled EMS or PPID.

• Resting or dynamic insulin is high.

• The horse is systemically ill.

• The horse has sepsis, endotoxemia, or severe inflammatory disease.

• The horse is already sore in multiple feet.

Action: do not treat casually. This needs direct veterinary assessment and a careful risk-benefit discussion.

When Is This an Emergency?

Call your vet urgently after corticosteroid treatment if your horse develops:

• Sudden reluctance to move

• Rocked-back stance

• Strong digital pulses

• Warm painful hooves

• Shifting weight

• Short, pottery gait

• Lameness in more than one foot

• Difficulty turning

• Depression or reduced appetite

• Fever

• Severe joint swelling after injection

• Severe lameness after a joint injection

• Heat, pain, or swelling at the injected joint

A hot, painful joint after injection is also urgent because septic arthritis must be ruled out. A study of 16,624 intra-articular injections in Thoroughbred racehorses found septic arthritis occurred in 13 joints, or 7.8 cases per 10,000 injections, and concluded that it is uncommon but important. (PubMed)

ACVS describes septic arthritis as a serious, potentially life-threatening condition that can rapidly damage articular cartilage, and notes that intra-articular injections can introduce bacteria even when sterile technique is used. (American College of Veterinary Surgeons)

Do not assume post-injection lameness is “just a flare” until infection has been considered.

What Are the Signs of Laminitis After Corticosteroids?

Watch for:

• Warm hooves

• Strong digital pulse

• Reluctance to walk

• Short, stiff, pottery gait

• Shifting weight from foot to foot

• Standing with the front feet stretched forward

• Pain turning in a tight circle

• Lameness affecting both front feet or all four feet

• Lying down more than normal

• Increased anxiety or reluctance to leave the stall

Laminitis after suspected corticosteroid exposure has often been reported within days to weeks in case reports, but timing is variable and many cases have underlying risk factors. The most practical approach is to monitor closely for the first week and continue watching carefully for several weeks, especially in high-risk horses. (veterinaryevidence.org)

If you are even slightly suspicious, act early.

Laminitis is much easier to manage before the horse is severely painful and before the coffin bone is destabilised.

What Should You Do Before a Cortisone Injection?

Before corticosteroid treatment, ask these questions:

1. What Is the Diagnosis?

A joint injection should follow a proper diagnosis, not just “the horse feels a bit off.”

Ideally, the painful region has been localised with:

• Lameness exam

• Flexion tests

• Hoof assessment

• Diagnostic nerve or joint blocks

• Radiographs

• Ultrasound

• Other imaging where needed

2. Is This Actually a Joint Problem?

Corticosteroids may be inappropriate if the main issue is tendon, ligament, or soft tissue injury. UC Davis notes that corticosteroids can move from joint spaces to surrounding soft tissues and delay healing, so they should not be used in horses with soft tissue injury. (Horse Report)

3. Is the Horse Metabolically Safe?

Check for:

• Previous laminitis

• Body condition

• Cresty neck

• Regional fat pads

• Easy keeper history

• PPID signs

• Recent insulin testing

• Diet and pasture exposure

4. What Steroid and Dose Are Being Used?

Ask your vet:

• Which corticosteroid?

• Which joint or site?

• What dose per site?

• What total dose?

• How many sites are being treated?

• Are there safer alternatives?

• What is the rest plan?

• What signs should I monitor?

5. Are Competition Rules Relevant?

If the horse competes, check withdrawal times and medication rules for your specific organisation before treatment. Rules vary and can change.

What Are Alternatives to Corticosteroids?

Alternatives depend on the diagnosis, joint, severity, budget, competition rules, and whether soft tissue injury is present.

Options may include:

• Rest and controlled exercise

• Corrective farriery

• NSAIDs under veterinary guidance

• Hyaluronic acid

• Polysulfated glycosaminoglycan

• PRP

• APS or autologous protein solution

• IRAP or autologous conditioned serum

• Polyacrylamide hydrogel

• Shockwave in selected cases

• Physiotherapy and rehabilitation

• Weight loss and metabolic control

• Saddle fit and training modification

• Surgery in selected cases

UC Davis lists several non-steroid intra-articular and biologic options, including hyaluronic acid, PRP, IRAP, and stem cells, while noting that evidence, preparation methods, and ideal use vary by product and condition. (Horse Report)

The key point: alternatives are not automatically better. Corticosteroids are not automatically worse. The right option depends on the horse.

What To Do After a Cortisone Injection

Follow your vet’s instructions, but a sensible post-treatment plan often includes:

• Stall or small-area rest initially

• No hard work immediately after injection

• Monitor injection sites

• Monitor gait daily

• Check digital pulses

• Check hoof warmth

• Watch appetite and attitude

• Avoid sudden diet changes

• Keep high-risk horses off lush pasture if advised

• Resume work gradually

• Report any worsening lameness, swelling, or foot soreness promptly

Ask your vet exactly how long to rest. Some horses need a short rest period before returning to controlled work. Others need a longer rehabilitation plan because the injection is only part of managing the underlying joint disease.

Do not let pain relief trick you into overworking the horse. A steroid can make a joint feel better before the joint is actually ready for full load.

That is how “he felt amazing after the injection” becomes “now we have a bigger problem.”

Common Mistakes Owners Make

1. Asking for Joint Injections Without a Diagnosis

Joint injections should be targeted. Injecting because the horse is “a bit stiff” can miss the real problem.

2. Ignoring Metabolic Risk

A cresty neck, previous laminitis, obesity, PPID, or insulin dysregulation should change the conversation.

3. Thinking There Is a Guaranteed Safe Dose

There is no universal dose that removes laminitis risk in every horse. The safest plan is risk-based.

4. Treating Too Many Sites at Once Without Considering Total Dose

The total corticosteroid exposure matters, not just each individual joint.

5. Not Testing Insulin Before Treatment in At-Risk Horses

Testing after corticosteroids may be harder to interpret, especially with triamcinolone.

6. Riding Too Hard Too Soon

Pain relief is not the same as healing. Rest and return-to-work planning matter.

7. Ignoring Post-Injection Lameness

Severe lameness after injection could be flare, laminitis, or joint infection. Do not guess.

8. Using Steroids Around Soft Tissue Injury Without Careful Thought

Steroids can delay soft tissue healing and may be inappropriate when tendon or ligament injury is present. (Horse Report)

How Can Laminitis Risk Be Reduced?

You cannot reduce risk to zero, but you can reduce it.

Practical steps include:

• Identify high-risk horses before treatment

• Test insulin in horses with obesity, cresty neck, easy keeper type, or previous laminitis

• Screen older horses for PPID where appropriate

• Use the lowest effective corticosteroid dose

• Track total dose across all joints or sites

• Avoid unnecessary repeated injections

• Avoid corticosteroids during active laminitis

• Consider non-steroid options in high-risk horses

• Keep diet controlled around treatment

• Avoid sudden pasture access changes

• Monitor digital pulses and hoof comfort after injection

• Use targeted diagnosis rather than broad “maintenance” injections

• Treat the underlying lameness cause, not just the inflammation

For metabolic horses, diet and exercise management remain central. Merck Veterinary Manual states that diet is the most important element in EMS management, and that grazing, grains, and treats should be eliminated for EMS patients, with low non-structural carbohydrate hay used as the foundation. (Merck Veterinary Manual)

Myth vs Reality

Myth	Reality
Cortisone always causes laminitis.	Evidence does not support a strong causal link in healthy metabolically normal horses, but risk is not zero.
Cortisone is always safe if injected into a joint.	Joint injections can still have systemic metabolic effects, especially with triamcinolone.
There is one safe dose for every horse.	There is no guaranteed safe dose that prevents laminitis in every horse.
Only ponies get steroid-related laminitis risk.	Ponies are high-risk, but any horse with insulin dysregulation, EMS, PPID, obesity, or prior laminitis deserves caution.
If the horse feels better, the joint is fixed.	Steroids reduce inflammation and pain. They do not reverse every underlying joint problem.
A post-injection painful joint is probably normal.	Flare is possible, but septic arthritis must be ruled out if pain, heat, swelling, or severe lameness occurs.

FAQs About Cortisone and Laminitis in Horses

Is cortisone dangerous for horses?

Corticosteroids are not automatically dangerous, but they are powerful drugs. They can be very useful when selected carefully, but they need extra caution in horses with metabolic disease, previous laminitis, obesity, PPID, insulin dysregulation, or severe systemic illness.

Can joint injections cause founder?

The risk appears low in healthy metabolically normal horses, but laminitis can occur and risk is higher when other risk factors are present. The evidence does not support panic, but it does support careful case selection and monitoring. (RCVS Knowledge)

What is the safest cortisone dose for horses?

There is no guaranteed safe dose. Some sources cite around 18 mg total triamcinolone as a commonly discussed upper limit, but that does not eliminate laminitis risk in every horse. Your vet should choose the lowest effective dose based on the horse, joint, diagnosis, and metabolic risk. (The Horse)

Should my horse have insulin tested before cortisone?

If your horse is overweight, cresty, an easy keeper, a pony or native type, older, previously laminitic, or suspected of EMS or PPID, insulin testing is sensible before corticosteroid treatment. Testing is especially useful before treatment because triamcinolone can affect insulin and endocrine test results for several days. (Merck Veterinary Manual)

What signs should I watch for after a joint injection?

Watch for foot soreness, warm hooves, strong digital pulses, reluctance to move, shifting weight, a pottery gait, severe lameness, fever, depression, or a hot swollen injected joint. Call your vet promptly if any of these appear.

The Bottom Line

Cortisone is not the villain of equine medicine.

It is also not harmless.

Corticosteroids can be extremely useful for managing inflammation and pain, especially in correctly diagnosed joint disease. In healthy, metabolically normal horses, the current evidence suggests the laminitis risk from appropriate intrasynovial corticosteroid use is low. But the risk conversation changes completely in horses with insulin dysregulation, EMS, PPID, obesity, cresty neck, previous laminitis, severe systemic illness, high total doses, or repeated exposure.

The safest approach is not fear. It is not casual use either.

The safest approach is diagnosis first, risk assessment second, lowest effective dose third, and careful monitoring after that.

A good steroid plan should answer four questions:

• Does this horse actually need a corticosteroid?

• Is this horse metabolically safe enough for it?

• Is there a lower-risk alternative?

• What exactly will we monitor afterward?

That is how corticosteroids stay useful without becoming reckless.

---

If your horse needs a joint injection or corticosteroid treatment and you are unsure about laminitis risk, ASK A VET™ can help you organise the risk factors, understand what questions to ask your vet, and decide whether metabolic screening or a safer treatment plan should be discussed.